The endocannabinoid system and liver diseases.
Subject: Liver Disease - PUBLISHED VIA Journal of Neuroendocrinology
Author(s):
Caraceni P, Domenicali M, Bernardi M
View Source >>
Related Studies:
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.
Published via British Journal of Pharmacology
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.
Published via Cell Death & Disease
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.
Published via European Journal of Pharmacology
Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
Published via PLOS ONE
Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
Published via Author Manuscript